癌细胞和诱导多能干细胞的相互转化
Drishty B Sarker1, Yu Xue1, Faiza Mahmud1
1Department of Chemistry and Biochemistry, Florida State University, Tallahassee, FL 32306-4390, USA.
Cells
|January 22, 2024
概括
诱导多能干细胞 (iPSCs) 可以被重新编程成癌症干细胞 (CSCs) 或反之,为研究癌症发病,耐药性和开发新疗法创造了有价值的模型.
科学领域:
- 在瘤学瘤学.
- 干细胞生物学 干细胞生物学
- 癌症研究 癌症研究
背景情况:
- 癌症干细胞 (CSCs) 与诱导多能干细胞 (iPSCs) 有着共同的分子特征.
- 重编程技术允许从恶性细胞生成诱导的多能癌细胞.
- 正常的iPSCs可以通过特定的操纵来获得类似于癌症干的特性.
研究的目的:
- 审查多能性因子在癌症干性,瘤性和治疗耐药性中的作用.
- 探索生成iPSC衍生CSC模型的方法,重点关注基于暴露的方法.
- 讨论将癌细胞重新编程为癌症iPSCs的潜力,以进行机制研究.
主要方法:
- 总结有关癌症多能性因素的现有文献.
- 描述从iPSC中获得CSC模型的方法,包括条件介质和共同培养技术.
- 研究癌细胞重新编程成癌症-iPSCs.
主要成果:
- 多能性因素显著影响癌症干,瘤性和耐药性.
- 基于暴露的方法,如条件介质和共同培养,有效地将iPSC转化为CSC类细胞.
- 将癌细胞重新编程成癌症-iPSCs有助于研究癌症的遗传,表观遗传和微环境因素.
结论:
- 整合iPSC技术为癌症研究提供了强大的模型.
- 这些模型提升了对瘤发生,耐药性和癌症依赖性的理解.
- 这种方法有望加速开发新的,个性化的癌症治疗方法.
更多相关视频
10:03Generation of Induced Pluripotent Stem Cells from Human Melanoma Tumor-infiltrating Lymphocytes
Published on: November 11, 2016
9.9K
10:15Conditional Reprogramming of Pediatric Human Esophageal Epithelial Cells for Use in Tissue Engineering and Disease Investigation
Published on: March 22, 2017
7.0K
相关概念视频
Induced Pluripotent Stem Cells
4.1K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.1K
iPS Cell Differentiation
2.7K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K
Methods of Nuclear Reprogramming
1.8K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
1.8K
Cancer Stem Cells and Tumor Maintenance
4.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K
Stem Cell Culture
5.2K
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
5.2K
Somatic to iPS Cell Reprogramming
2.2K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.2K
